Pathogenesis and treatment of dialysis hypotension

Kidney International

Volumn 70, Issue SUPPL. 104, 2006, Pages

  Sulowicz, W ^a   Radziszewski, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Blood volume; Dialysis hypotension; Hemodialysis; Hypovolemia; Mortality

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; MIDODRINE; VASOPRESSIN DERIVATIVE;

BLOOD VOLUME; CARDIOVASCULAR DISEASE; COMORBIDITY; DIABETIC PATIENT; DIALYSATE; DIALYSIS; GERIATRIC PATIENT; HUMAN; HYPOTENSION; PATHOGENESIS; PATIENT ASSESSMENT; PATIENT EDUCATION; PLASMA OSMOLALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; ULTRAFILTRATION;

EID: 33751102624     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001975     Document Type: Article

References (30)

1. Shoji T, Tsubakihara Y, Fujii M et al. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66: 1212-1220.
2. Nurmohamed SA, Nube MJ. Reverse epidemiology: paradoxical observations in haemodialysis patients. Neth J Med 2005; 63: 376-381.
3. Dasselaar JJ, Huisman RM, de Jong PE et al. Measurement of relative blood volume changes during haemodialysis: merits and limitations. Nephrol Dial Transplant 2005; 20: 2043-2049.
4. Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int 2001; 59: 1175-1181.
5. Daugirdas JT. Preventing and managing hypotension. Semin Dial 1994; 7: 276-283.
6. Stegmayr B, Ptak J, Wikstrom B et al. World apheresis registry: report of 2004 data. Ther Apher Dial 2005; 9: A38.
7. Santoro A, Mancini E, Basile C et al. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial. Kidney Int 2002; 62: 1034-1045.
8. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38(Suppl 4): 11-17.
9. Imai E, Fujii M, Kohno Y et al. Adenosine A1 receptor antagonist improves intradialytic hypotension. Kidney Int 2006; 69: 877-883.
10. Sarkar SR, Kaitwatcharachai C, Levin NW. Nitric oxide and hemodialysis. Semin Dial 2004; 17: 224-228.
11. Sato M, Horigome I, Chiba S et al. Autonomic insufficiency as a factor contributing to dialysis-induced hypotension. Nephrol Dial Transplant 2001; 16: 1657-1662.
12. Hoeben H, Abu-Alfa AK, Mahnensmith R et al. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine. Am J Kidney Dis 2002; 39: 102-107.
13. Harper SJ, Tomson CRV, Bates DO. Human uremic plasma increases microvascular permeability to water and proteins in vivo. Kidney Int 2002; 61: 1416-1422.
14. Barth C, Boer W, Garzoni D et al. Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume? Nephrol Dial Transplant 2003; 18: 1353-1360.
15. Sklar A, Newman N, Scott R et al. Identification of factors responsible for postdialysis fatigue. Am J Kidney Dis 1999; 34: 464-470.
16. Hossli SM. Clinical management of intradialytic hypotension: survey results. Nephrol Nurs J 2005; 32: 287-291.
17. Knoll GA, Grabowski JA, Dervin GF et al. A randomized, controlled trial of albumin versus saline for the treatment of intradialytic hypotension. J Am Soc Nephrol 2004; 15: 487-492.
18. Yu AW, Ing TS, Zabaneh RI et al. Effect of dialysate temperature on central hemodynamics and urea kinetics. Kidney Int 1995; 48: 237-243.
19. Song JK, Lee SW, Suh CK et al. Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 2002; 40: 291-301.
20. Hampl H, Berweck S, Ludat K et al. How can hemodialysis-associated hypotension and dialysis-induced symptoms be explained and controlled - particularly in diabetic and arteriosclerotic patients? Clin Nephrol 2000; 53(Suppl 1): 69-79.
21. Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N et al. A crossover study of short daily haemodialysis. Nephrol Dial Transplant 2006; 21: 166-175.
22. Okada K, Abe M, Hagi C et al. Prolonged protective effect of short daily hemodialysis against dialysis-induced hypotension. Kidney Blood Press Res 2005; 28: 68-76.
23. Moret K, Aalten J, Wall Bake W et al. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients. Nephrol Dial Transplant 2006; 21: 138-144.
24. Donauer J. Hemodialysis-induced hypotension: impact of technologic advances. Semin Dial 2004; 17: 333-335.
25. Prakash S, Garg AX, Heidenheim AP et al. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant 2004; 19: 2553-2558.
26. Yalcin AU, Kudaiberdieva G, Sahin G et al. Effect of sertraline hydrochloride on cardiac autonomic dysfunction in patients with hemodialysis-induced hypotension. Nephron Physiol 2003; 93: 21-28.
27. Mercadal L, Petitclerc T. Effect of mineralocorticoids on interdialytic weight gain in hemodialysis patients with perdialytic hypotension. Hemodial Int 2005; 9: 338-340.
28. Franssen CMF. Adenosine and dialysis hypotension. Kidney Int 2006; 69: 789-791.
29. Handelman GJ. Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy. Blood Purif 2006; 24: 140-142.
30. Schreiber BD. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients. Blood Purif 2006; 24: 128-139.